These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 31096217

  • 21. Interaction of CREB and PGC-1α Induces Fibronectin Type III Domain-Containing Protein 5 Expression in C2C12 Myotubes.
    Yang XY, Tse MCL, Hu X, Jia WH, Du GH, Chan CB.
    Cell Physiol Biochem; 2018; 50(4):1574-1584. PubMed ID: 30359971
    [Abstract] [Full Text] [Related]

  • 22. C2C12 myoblastoma cell differentiation and proliferation is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression.
    Diel P, Baadners D, Schlüpmann K, Velders M, Schwarz JP.
    J Mol Endocrinol; 2008 May; 40(5):231-41. PubMed ID: 18434429
    [Abstract] [Full Text] [Related]

  • 23. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
    Hofbauer LC, Ten RM, Khosla S.
    J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
    [Abstract] [Full Text] [Related]

  • 24. Androgen receptor activation integrates complex transcriptional effects in osteoblasts, involving the growth factors TGF-β and IGF-I, and transcription factor C/EBPδ.
    McCarthy TL, Centrella M.
    Gene; 2015 Nov 15; 573(1):129-40. PubMed ID: 26187065
    [Abstract] [Full Text] [Related]

  • 25. Higher glucose availability augments the metabolic responses of the C2C12 myotubes to exercise-like electrical pulse stimulation.
    Lautaoja JH, M O'Connell T, Mäntyselkä S, Peräkylä J, Kainulainen H, Pekkala S, Permi P, Hulmi JJ.
    Am J Physiol Endocrinol Metab; 2021 Aug 01; 321(2):E229-E245. PubMed ID: 34181491
    [Abstract] [Full Text] [Related]

  • 26. Androgen receptor expression during C2C12 skeletal muscle cell line differentiation.
    Wannenes F, Caprio M, Gatta L, Fabbri A, Bonini S, Moretti C.
    Mol Cell Endocrinol; 2008 Sep 24; 292(1-2):11-9. PubMed ID: 18588941
    [Abstract] [Full Text] [Related]

  • 27. Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression.
    Kanno Y, Ota R, Someya K, Kusakabe T, Kato K, Inouye Y.
    Biol Pharm Bull; 2013 Sep 24; 36(9):1460-5. PubMed ID: 23995658
    [Abstract] [Full Text] [Related]

  • 28. Neural androgen receptor regulation: effects of androgen and antiandrogen.
    Lu S, Simon NG, Wang Y, Hu S.
    J Neurobiol; 1999 Dec 24; 41(4):505-12. PubMed ID: 10590174
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Activating transcription factor 3 regulates chemokine expression in contracting C2C12 myotubes and in mouse skeletal muscle after eccentric exercise.
    Fernández-Verdejo R, Vanwynsberghe AM, Hai T, Deldicque L, Francaux M.
    Biochem Biophys Res Commun; 2017 Oct 14; 492(2):249-254. PubMed ID: 28822763
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting.
    Oyabu M, Takigawa K, Mizutani S, Hatazawa Y, Fujita M, Ohira Y, Sugimoto T, Suzuki O, Tsuchiya K, Suganami T, Ogawa Y, Ishihara K, Miura S, Kamei Y.
    FASEB J; 2022 Feb 14; 36(2):e22152. PubMed ID: 35061305
    [Abstract] [Full Text] [Related]

  • 40. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
    Kai L, Levenson AS.
    Anticancer Res; 2011 Oct 14; 31(10):3323-30. PubMed ID: 21965742
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.